Medicina
Departamento
University of Montreal
Montreal, CanadáPublicaciones en colaboración con investigadores/as de University of Montreal (25)
2024
-
Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies
Journal of neurology, Vol. 271, Núm. 1, pp. 472-485
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Comparison of the Accuracy of the 7-Item HADS Depression Subscale and 14-Item Total HADS for Screening for Major Depression: A Systematic Review and Individual Participant Data Meta-Analysis
Psychological Assessment, Vol. 35, Núm. 2, pp. 94-114
-
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis
Multiple sclerosis (Houndmills, Basingstoke, England), Vol. 29, Núm. 7, pp. 875-883
2022
-
Managing food allergy: GA2LEN guideline 2022
World Allergy Organization Journal, Vol. 15, Núm. 9
2021
-
The safety and efficacy of dasatinib plus nivolumab in patients with previously treated chronic myeloid leukemia: results from a phase 1b dose-escalation study
Leukemia and Lymphoma
-
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
npj Breast Cancer, Vol. 7, Núm. 1
2019
-
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
American Journal of Human Genetics, Vol. 104, Núm. 1, pp. 21-34
2017
-
Association analysis identifies 65 new breast cancer risk loci
Nature, Vol. 551, Núm. 7678, pp. 92-94
-
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
Nature Genetics, Vol. 49, Núm. 12, pp. 1767-1778
2014
-
Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: Final analysis of a multicentre, open-label, early-access protocol trial
The Lancet Oncology, Vol. 15, Núm. 11, pp. 1263-1268
-
Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the international scleroderma renal crisis survey
Seminars in Arthritis and Rheumatism, Vol. 43, Núm. 5, pp. 666-672
-
Macrophage infection via selective capture of HIV-1-infected CD4+ T cells
Cell Host and Microbe, Vol. 16, Núm. 6, pp. 711-721
-
Randomized, placebo-controlled, phase III trial of sunitinib plus prednisone versus prednisone alone in progressive, metastatic, castration-resistant prostate cancer
Journal of Clinical Oncology, Vol. 32, Núm. 2, pp. 76-82
2013
-
Health-related quality of life as a main determinant of access to rheumatologic care
Rheumatology International, Vol. 33, Núm. 7, pp. 1797-1804
2012
-
An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy
European Journal of Cancer, Vol. 48, Núm. 3, pp. 324-332
-
Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis
Kidney International Supplements, Vol. 2, Núm. 2, pp. 139-274
2009
-
Nitric oxide increases cardiac ik1 by nitrosylation of cysteine 76 of Kir2.1 Channels
Circulation Research, Vol. 105, Núm. 4, pp. 383-392
2005
-
Appropriateness of the use of physical restraints and psychotropic medication in institutionalised older people: Comparative study in Quebec and French Switzerland. Applicability to Spain
Revista Espanola de Geriatria y Gerontologia, Vol. 40, Núm. 1, pp. 7-17
1991
-
Metabolism of lactate by a suspension of dog thick ascending limbs: Relations with transport
Kidney and Blood Pressure Research, Vol. 14, Núm. 1-2, pp. 28-41